Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hepatic Vein Pressure Gradient(HVPG)-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Patients With Liver Cirrhosis: A Prospective Randomized Controlled Trial

NCT04254822 is registered in ClinicalTrials.gov with Air Force Military Medical University, China as lead sponsor.

NCT NCT04254822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04254822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hepatic Vein Pressure Gradient(HVPG)-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Patients With Liver Cirrhosis: A Prospective Randomized Controlled Trial
Lead sponsor
Air Force Military Medical University, China
Phase
Not applicable
Overall status
Unknown status
Start date
June 1, 2020
Completion date
December 31, 2023
Enrollment
220 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal varices, liver cirrhoses, variceal hemorrhage